The potent and selective activity of 6-methoxypurine arabinoside (9B[I3-D-arabinofuranosyl]-6-methoxy-9H-purine; 1) and its pharmacokinetic limitations have been described previously. In an attempt to circumvent first-pass catabolism following oral administration, a series of 5 ' -esters (2a-t) was prepared by dicyclohexyl-carbodiimide-promoted condensation with formic acid in the case of 2a, or by direct acylation of the parent nucleoside with the corresponding acyl chloride. These compounds were evaluated in rats for efficacy as oral prodrugs of 1 by measuring the amount of 1 excreted in the urine. Both aliphatic and aromatic esters exhibited a range of systemic availabilities. The substituted benzoate esters showed a correlation between the amount of 1 excreted and the electron-donating properties of the substituent. A similar relationship was observed for the relative stabilities of this series of esters to non-enzymatic hydrolysis at neutral pH. No clear relationship between systemic availability and solubility, partition coefficient, or stability was observed for the remaining esters of 1. Although significant enhancements in systemic availability were observed with some of the 5 ' -esters of this series, their limited water solubility precluded their use in intravenous formulations. Received . (1975) ara-Cytidine acylates. Use of drug design predictors in structure-activity relationship correlation. J Med Chem 18: 339--344. r ,
Introduction 6-Methoxypurine arabinoside (9-[I3-D-arabinofuranosyl] -6-methoxy-9H-purine; 1) is a potent and selective antiviral agent for varicella-zoster virus in vitro (Averett et al., 1991a) . Enzyme and in vivo studies indicate that adenosine deaminase catabolizes 1 to hypoxanthine arabinoside, which is then excreted or further metabolized (Averett et al., 1991b; Burnette et et., 1991) . A significant first-pass effect was indicated by the dramatic differences in urinary recovery of unchanged 1 following oral and intraperitoneal administration (Burnette et al., 1991) . Since the intestinal mucosa has high levels of adenosine deaminase (Ho et al., 1980) , a prodrug of 1 that is protected from deamination during absorption may be a more effective oral agent. Substitution of the 2 /or 5'-hydroxyl of adenosine is known to lead to compounds resistant to the action of adenosine deaminase (Shah et al., 1965; Bloch et al., 1967; Schaeffer et al., 1971; Hampton et al., 1972) . In an earlier report we described the synthesis and evaluation of a series of di-and tri-esters of 1, which indicated that the 2' ,3 /-diacetate provided enhanced bioavailability and water solubility, whereas the 2',5 /and 3',5 /-diacetates showed enhanced bioavailability with diminished aqueous solubility (Jones et al., 1991) . In the hope of attaining still greater improvements in the systemic availability of 1 and a better understanding of the regiochemical effects of esterification on solubility, we undertook the synthesis and evaluation of a series of 5 /-monoesters of 1 (2a-2t). The results of these efforts are reported here.
Results

Chemistry
The 5 '-formyl ester (2a) was prepared by a dicyclohexylcarbodiimide-promoted condensation of 1 with formic acid (Scheme 1). The preparation of the remaining 5 /esters of 1 was accomplished by treating a solution of the arabinoside in acetonitrile and pyridine with a slight excess of the appropriate acid chloride (Scheme 1). In all cases, complex mixtures were formed, from which the 5'-ester could be isolated as the major product by standard chromatographic methods (Table 1) .lf an excess of pyridine was not used to dissolve 1 completely, the major products were dl-and/or tri-esters with significant amounts of 1 being recovered.
Attempts to enhance the selectivity of acylation at reduced temperatures were unsuccessful. The use of anhydrides rather than acid chlorides led to the 2' -esters rather than 5 '-esters as the major product. Baker and coworkers (1978) utilized dimethylformamide and pyridine as a solvent mixture in the preparation of a series of 5'-esters of adenine arabinoside with good results. With 1 we detected no significant improvement in the selectivity of acylation by using dimethylformamide in place of acetonitrile. The use of acetonitrile rather than dimethylformamide had the advantage of ease of solvent removal for isolation of products.
All compounds were characterized on the basis of their 1HNMR,IR, UV, and mass spectra. In the 1HNMRspectra, the absence of a triplet for the 5' -OH and a characteristic downfield shift of -0.65-1.05 ppm for the protons at C-5' was observed (Table 2) , reflecting that acylation had occurred at the 5'-position. Downfield shifts of 0.15-0.35 ppm were also observed for the proton at C-4', with virtually no shift of signals for the protons at C-3' and C-2'. The 1H-NMR also indicated that the purine nucleus was intact, based upon the extremely stable chemical shifts of H-2, H-8, and the methoxy-group protons.
The infrared spectra (Table 1) confirmed the presence of an intact purine nucleus (-1600cm-1) and an ester carbonyl. For compounds 2k and 2t, the presence of a sulphonate ester was reflected by bands at -1350 and 1175cm-1.
Classic fragmentation patterns (McCloskey, 1974) were observed for the compounds in their electron impact (EI) and chemical ionization (CI) mass spectra (data not shown). In addition to frequently observing the molecular ion as M+H, we routinely observed a fragment at m/z 265, indicating loss of the carboxylate (M-Acid). In the CI spectra, a fragment at m/z 283 was also seen, indicating loss of the acyl moiety. The presence of a fragment at rn/z 193 in the EI spectra provided further support that the 2'-hydroxyl is not acylated. Shaw et al. (1970) indicated that such a fragment should arise from cleavage of the furanose ring between C-2'/C-3' and between C-1'/O-4' when the 2'-substituent is an hydroxyl group. A second peak at rn/z 179, thought to contain the base, C-1', and the sugar ether oxygen, was also consistent with the lack of acylation at the 2'-hydroxyl (Biemann and McCloskey, 1962; Shaw et al., 1970) . With the aliphatic esters, a fragment corresponding to the acylated sugar (M-Base) was routinely observed. Taken together, the data clearly support the assignment of these compounds as the 5'-(O-acyl) derivatives of 1.
Biological evaluation
Compounds 2a-t were evaluated as prodrugs of 6methoxypurine arabinoside (1).The systemic availability of 2a-t was estimated by the 48-h urinary recovery of intact 1 following oral administration (Table 3 ). The value of this approach and its application to other antiviral nucleoside analogues has been reported (Gibaldi and Perrier, 1975; Krasny et al., 1981; Krenitsky et al., 1984) . The rate of absorption and distribution of various nucleoside analogues has been shown to be related to their lipid and aqueous solubilities (Repta et al., 1975; Wechter et al., 1975; Baker et al., 1979; Benjamin et al., 1987) . As approximations of these parameters, estimates of the partition coefficients and solubilities in phosphate buffered saline were determined for the various prod rugs (Table 3 ). In addition, the stabilities of the compounds to non-enzymatic hydrolysis at neutral pH were determined.
Discussion
Oral administration of either aliphatic or aromatic 5'-esters of 1 enhanced the availability of 1 in rats, as determined by the 48-h urinary recoveries of unchaged 1 (Table 3) . However, the two sulphonate esters, 2k and 2t, were not significantly better than 1 itself. This may reflect the lability of these compounds to acid pH (data not shown). When administered orally, these compounds are probably degraded rapidly at the pH of the rat stomach, approximately pH = 2 (Ekelund et al., 1985) , and may therefore be presented to the small intestine as 1 rather than 2k or 2t.
Administration of the 5'-acetate (2b) led to a significant enhancement in the amount of 1 excreted in the urine over that of 1 itself. This improvement decreased with increasing chain length from acetate to butyrate. Further increases in chain length led to alternating increases and decreases in the amount of 1 recovered in the urine. The aromatic esters were quite a different case. The electronic effects of substituents acted in a predictable fashion to enhance or diminish systemic availability of 1. When the data for 21-p were plotted in the format of the Hammett equation, an excellent linear relationship was observed between the electron donating properties of the aromatic substituent and the urinary recovery of 1 derived from the prodrug (r2 = 0.935). However, this relationship fails to account for the low urinary recovery of 1 following oral administration of the 4-aminobenzoyl monoester (2q) (7.9% vs. a predicted 20%). It is unlikely that this is simply a reflection of protonation of the compound in vivo, thereby limiting its absorption from the GI tract, since such amines are only weakly basic (pKa -2.5) (Albert and Serjeant, 1971) . The insertion of a methylene or oxymethylene (2r or 2s vs. 21) between the aromatic ring and the carbonyl was unfavourable. In the case of 2s, this may be a reflection of the instability of the ester linkage.
Although an interesting and potentially useful relationship was observed for the electron-donating properties of substituents on the aromatic esters and the urinary recovery of 1 derived from these prodruqs, no such relationship could be drawn from the aqueous solubility or estimated log P data in Table 3 . It is clear that aqueous solubility is not the limiting factor in the systemic availability of these prod rugs, because 2b and 20 had nearly identical urinary recoveries, with solubilities differing approximately 270-fold. Similarly, 21 and 2p had identical estimated log P values, but following oral administration gave dramatically different urinary recoveries of 1, indicating the low predictive value of this parameter. Non-enzymatic hydrolysis can also be ruled out as a critical factor in determining the utility of these compounds as prod rugs of 1; most of the compounds hydrolyzed to 1 much too slowly to account for the levels recovered in the urine.
While the compounds described here pose interesting possibilities as prodrugs of 1, they lack any significant improvement in aqueous solubility needed to facilitate the development of an intravenous formulation. Our previous observations that the 2' ,3' -diacetate of 1 shows enhanced aqueous solubility while the 2',5'-and 3',5'-diacetates have diminished solubility (Jones et al., 1991) suggest that the 5'-hydroxyl group plays a prominent role in the aqueous solubility of 1. The lack of enhanced solubility observed with the compounds in this paper support this hypothesis and suggest that esterification of the 2'-or 3'-hydroxyl group of 1 will lead to substantial enhancements in aqueous solubility. Baker et al. (1979) arrived at a similar conclusion with diesters of adenine arabinoside. Our studies with the 2'-esters of 1 will be reported separately.
Materials and Experimental procedures
Materials 6-Methoxypurine arabinoside (1) was prepared as previously described (Averett et al., 1991a) . Toluenesulphonyl chloride was freshly recrystallized from CCI 4 immediately prior to use. Phenylacetic anhydride was purchased from Parish Chemical Company (Orem, UT, USA). All other chemicals were purchased from Aldrich Chemical Company (Milwaukee, WI, USA); these were of the highest purity available and were used without further purification. Silica gel products were purchased from EM Science (Cherry Hill, NJ, USA). Flash chromatography was carried out using Kieselgel60, 230-400 mesh. Analytical TLC was performed on Kieselgel 60 F 2 5 4 (0.2mm thickness) plastic-backed sheets. Preparative layer chromatography was performed on Kieselgel60 F 2 5 4 (2.0mm thickness) glass-backed plates. The 0.22-micron nylon filters used for filter sterilization were purchased from Millipore (Bedford, MA, USA), and the 0.2-micron nylon filters used for HPLC sample preparation were purchased from Alltech Associates (Avondale, PA, USA). HPLC was carried out on a Perkin Elmer System 4 liquid chromatograph equipped with a Perkin Elmer LC-95 variable wavelength detector, ISS-100 autoinjector, and LCI-100 integrator, unless otherwise indicated. The columns used were a Zorbax ODS 4.6 x 250mm, 5-micron column (Wilmington, DE, USA) and an Alltech/Applied Sciences C-18, 4.6 x 250 mm, 1O-micron column (State College, PA, USA).
General methods
Melting points were determined on a Thomas Hoover UniMelt® apparatus and are uncorrected. Ultraviolet spectra were recorded using a Perkin Elmer Lambda 7 spectrometer equipped with a thermoelectric cell holder set to either 25.0°C or 37.0°C, as indicated by a digital readout from a thermistor in each cell holder. 'H NMR spectra were recorded in a Varian or a Varian XL-300 (299.945 MHz) spectrometer and are reported relative to tetramethylsilane. Assignments of H-8 and H-2 were not unequivocal and may be reversed. Mass spectra were recorded by Oneida Research Services (Whitesboro, NY, USA).A . Mattson Cygnus 1OO® Fourier transform spectrometer interfaced to a Pixel 80® microcomputer was used in recording infrared spectra. Elemental analyses were performed by Atlantic Microlabs (Atlanta, GA, USA).
9-(S-O-formyl-f3-D-arabinofuranosy/}-6-methoxy-9H-purine (2a).
Compound 1 (1.03g, 3.65mmol) was added to a solution of 1,3-dicyclohexylcarbodiimide (4.28g, 20.54 mmol) in anhydrous CH3CN (30ml) and dimethylformamide (10ml). To this solution was added formic acid (0.5ml, 12.72 mmol) in anhydrous CH 3CN (5ml) over a 1O-min interval. This mixture was stirred under argon for 3.5 h at room temperature, then quenched with the addition of CHCIs (120ml). Dicyclohexylurea was removed by filtration and the filtrate was evaporated to dryness. The residue was twice treated with cold, dry ethyl acetate (100ml), stored at -1 T'C for 3 d, and filtered to remove additional dicyclohexylurea. After evaporating to a heavy oil, the residue was purified by preparative layer chromatography to obtain the desired compound as a white solid.
General synthesis of S'-esters of 6-methoxypurine arabinoside (2b-2p, 2r-2t) . Compound 1 (1.00g, 3.54 mmol) was suspended in anhydrous CH 3CN (35ml) and pyridine (10ml) was added to effect complete solution; the solution was chilled to 3°C and the appropriate acid chloride (3.90 mmol) was added. The mixture was stirred under argon for the specified period of time, allowing it to warm to room temperature; it was quenched with ethanol, evaporated to dryness, and then co-evaporated with ethanol (2 x 30ml). The product was purified by flash chromatography on silica gel (25g rnmor ') with the solvent system indicated in Table   1 .
9-(S-O-(4-aminobenzoyl-f3-D-arabinofuranosy/}]-6-methoxy-9Hpurine (2q). 6-Methoxy-9-(5-0-[4-nitrobenzoyll-~-D-arabinofura nosyl)-9H-purine (2e, 0.350g, 0.81 mmol) was suspended in ethanol (100ml) and 10% palladium-on-carbon (0.100g) was 5'-ester prodrugs of 6-methoxypurine arabinoside 145 added. Arter alternately evacuating and charging the system with hydrogen, the reaction was shaken on a Parr apparatus at 50 psi for 3 h. The mixture was then filtered through Celite and the filtrate was evaporated to dryness. The residue after evaporation was suspended in methanol and filtered to obtain the desired compound as a white solid.
Determination of solubilities
A sufficient amount of each of the esters to prepare a saturated solution was mixed with 1.0 ml of phosphate buffered saline, pH 7.2 (8.0g of sodium chloride, 0.15g of disodium hydrogen phosphate, and 0.03g of potassium dihydrogen phosphate in water to make 1.0 I)and agitated at 3rC for 2 h. The samples were then filtered through 0.2-micron nylon filters and the ultraviolet spectrum was recorded. The absorbance at the A ma x was used to determine the concentration of the saturated solution.
Determination of stabilities
Solutions of each of the esters (10-20 fLM, 50 ml) were prepared in 50mM potassium phosphate buffer, pH 7.00, filter sterilized into approximately 2-ml aliquots, and incubated at 3rC. At various times, samples were withdrawn and analyzed directly by HPLC on aZorbax ODS column. The sample was eluted at2.0ml mlrr" with a linear gradient from 10% CH 3CN in water to 50% CH 3CN over 10 min, followed by a linear gradient to 100% CH 3CN over 5 min. A variable wavelength detector set at 254nm was used to monitor the eluate. Original conditions were regenerated with a 5-min linear gradient followed by a 15-min re-equilibration phase. The rate of hydrolysis to 6-methoxypurine arabinoside (1) was determined. No decomposition of compound 1 was observed under these conditions over a period of 9 weeks.
Estimation of octanol-water partition coefficients
Octanol-water partition coefficients (log P) for the esters were estimated by correlation with their chromatographic capacity factors (k') according to the method of Haky and Young (1984) , using an Alltech RP-18, 4.6 x 250mm, 10-micron column. The mobile phase used was 55% methanol, 45% aqueous ammonium phosphate buffer(0.05M, pH 7.0)at a flowrateof2.0ml rnln". Samples were dissolved in methanol (1 mg ml-') for injection. Results are the average of three separate determinations.
Prodrug disposition studies
Two Long Evans male rats were dosed by gavage through an intragastrictube with 10 mg kg-' of 6-methoxypurine arabinoside (1), or the molar equivalent of a prodrug, dissolved or uniformly suspended in water containing 0.1% Tween 80. All animals were drug naive prior to this single administration. The animals were then housed together in a metabolic cage for 48 h and given food and water ad libitum. Urine was collected for 0-24 and 24-48 h following administration of the test compound. Urinary output was monitored to assure that it was within normal values (25 ± 5 ml rae' day-') during these collection periods. Samples of the pooled urine were then filtered through 0.22-micron nylon filters. A WISp® automatic injector was used to inject 100 fLl of the filtered urine sample onto an Alltech/Applied Sciences C-18 146 A. R. Moorman et al. column. The sample was eluted with a 45-min linear gradient of 0-20% CHsCN in 25 mM phosphoric acid previously adjusted to pH 7.2 with ammonium hydroxide, followed by a 1O-min purge of 80% CHsCN in distilled water. Two variable wavelength detectors set at 252 nm and 259 nm were used to monitor the eluate. Original conditions were regenerated with a 4-min linear gradient followed by a 15-min re-equilibration phase. The standard error of these determinations was found to be less than 15% of the reported value as determined by multiple experiments (3-7) with representative compounds.
